GBD 2017 Risk Factor Collaborators.
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet2018;
392: 1923–1994.
2.
RothGAAbateDAbateKH, et al.
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the global burden of disease study 2017. Lancet2018;
392: 1736–1788.
3.
BrayFFerlayJSoerjomataramI, et al.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2018;
68: 394–424.
4.
MozaffarianDBenjaminEJGoAS, et al.
Executive summary: Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation2016;
133: 447–454.
5.
YabroffKRLundJKepkaD, et al.
Economic burden of cancer in the United States: Estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev2011;
20: 2006–2014.
6.
BotsSHPetersSAWoodwardM.Sex differences in coronary heart disease and stroke mortality: A global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health2017;
2: e000298.
7.
SiegelRMillerKJemalA.Cancer statistics, 2017. CA Cancer J Clin2017;
67: 7–30.
RossRBlairSNArenaR, et al.
Importance of assessing cardiorespiratory fitness in clinical practice: A case for fitness as a clinical vital sign: A scientific statement from the American Heart Association. Circulation2016;
134: e653–e699.
10.
LeeDCArteroEGSuiX, et al.
Mortality trends in the general population: The importance of cardiorespiratory fitness. J Psychopharmacol2010;
24: 27–35.
11.
LaukkanenJAKurlSSalonenR, et al.
The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: A prospective population-based cohort study. Eur Heart J2004;
25: 1428–1437.
12.
SawadaSSLeeI-MNaitoH, et al.
Cardiorespiratory fitness, body mass index, and cancer mortality: A cohort study of Japanese men. BMC Public Health2014;
14: 1012.
13.
SuiXLaMonteMJBlairSN.Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men. Am J Epidemiol2007;
165: 1413–1423.
14.
VainshelboimBChanKChenZ. Cardiorespiratory fitness and cancer in men with cardiovascular disease: Analysis from the Veterans Exercise Testing Study. Eur J Prev Cardiol. Epub ahead of print 1 April 2020. DOI: 10.1177/2047487320916595.
15.
ParkS-YZhuKPotterJF, et al.
Health-related characteristics and dietary intakes of male veterans and non-veterans in the multiethnic cohort study (United States). J Mil Veterans Health2011;
19: 4–9.
16.
ReederDNGilletteMAFranckAJ, et al.
Clinical experience with ranolazine in a veteran population with chronic stable angina. Ann Pharmacother2012;
46: 42–50.
17.
ScottJMNilsenTSGuptaD, et al.
Exercise therapy and cardiovascular toxicity in cancer. Circulation2018;
137: 1176–1191.
18.
HowdenEJBigaranABeaudryR, et al.
Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol2019;
26: 305–315.
19.
D’AscenziFAnselmiFFiorentiniC, et al.
The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology. Eur J Prev Cardiol, Epub ahead of print 6 October 2019. DOI: 10.1177/2047487319874900.
20.
SaeidifardFMedina-InojosaJRWestCP, et al.
The association of resistance training with mortality: A systematic review and meta-analysis. Eur J Prev Cardiol2019;
26: 1647–1665.
21.
HojmanPGehlJChristensenJF, et al.
Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab2018;
27: 10–21.
